Table 1 Characteristics of the patients included in the study
Variables | All patients (n = 690) |
|---|---|
Age, yr, mean (SD) | 50.3 ± 19 |
Male sex, n (%) | 358 (52 %) |
APACHE II score | 16 [10–21] |
Type of admission, n (%) | Â |
 Medical | 550 (80 %) |
 Surgical | 140 (20 %) |
Comorbidities | Â |
 Number of comorbidities, n [IQR] | 1 [0–2] |
 Hypertension, n (%) | 346 (50 %) |
 Diabetes, n (%) | 149 (22 %) |
 COPD, n (%) | 59 (9 %) |
 Heart failure, n (%) | 110 (16 %) |
 Chronic kidney disease, n (%) | 113 (16 %) |
 AIDS, n (%) | 18 (3 %) |
 Cancer, n (%) | 71 (10 %) |
Reason for admission, n (%) | Â |
 Acute respiratory failure | 220 (32 %) |
 Shock | 125 (18 %) |
 Septic shock | 111 (16 %) |
 CNS disorder | 78 (11 %) |
 Monitoring | 73 (10 %) |
 Post-operative period | 48 (7 %) |
 Gastrointestinal diseases | 50 (7 %) |
 Electrolyte disturbances | 25 (4 %) |
 Acute kidney injury | 23 (3 %) |
 Trauma | 22 (3 %) |
Support during ICU stay, n (%) | Â |
 Mechanical ventilation | 510 (74 %) |
 Renal replacement therapy | 102 (15 %) |
 Vasopressors | 281 (41 %) |
SOFA score, median [IQR] | Â |
 At admission | 4 [2–7] |
 Maximum | 6 [3–9] |
 At ICU discharge | 2 [1–3] |
At least one organ failure,a n (%) | Â |
 At admission | 360 (52 %) |
 Maximum | 428 (62 %) |
 At ICU discharge | 129 (19 %) |
ICU length of stay, days | Â |
 Mean ± SD | 10 ± 9 |
 Median [IQR] | 7 [4–11] |
Albumin at discharge (g/L) | 27 [23–31] |